Neuroendocrine tumors such as merkel cell carcinoma (Figure 1E), small cell carcinoma of lung (Figure 1F), and pancreatic neuroendocrine tumors showed CD171-positivity in 82-85% of cases, generally in a majority of tumor cells. This evidence concerns the gene L1CAM and neoplasm.